The 340B program, which was created to give discounted prescription drugs to poor Americans, is riddled with abuse. The program has created a perverse incentive for providers to profit instead of effectively serve the poor and is hurting overall health care quality....
This brief explores a tool that millions of Americans use every day when paying for prescription drugs, Pharmacy Benefit Managers, or PBMs, which impact prescription drug costs, access, and patient care. ...
A more realistic evaluation of U.S. prescription drug prices shows that high drug prices are not actually driving up health care costs overall and reflect the higher U.S. health care costs compared to the rest of the world....
De facto price controls will impose heavy costs on Nevada that include higher health care costs and lower health care quality....
The bill is a creative way to impose price controls, which will impose heavy costs on Oregon, that include higher health care costs, and lower health care quality....
Responding to the problem of drug-resistant infections and the decline in the development of new antibiotics, this study explores ways to incentivize the development of new treatments that will effectively address this growing public health crisis....
Innovations in the pharmaceutical industry have significantly improved health outcomes for patients and have made important contributions to the U.S. economy. Provisions in the 21st Century Cures bill would help address these problems by accelerating the approval process for innovative pharmaceutical drugs and as a result, extend the effective patent lives for new pharmaceutical innovations....
The study examines the market forces influencing the often dramatic price differences in pharmaceutical drugs before and after their patents expire....